| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,744 |
1,639 |
$227K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,240 |
1,169 |
$114K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
888 |
888 |
$103K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
916 |
867 |
$101K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,427 |
2,376 |
$53K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
298 |
296 |
$37K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
306 |
306 |
$35K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
201 |
201 |
$25K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
521 |
516 |
$6K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
161 |
159 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
119 |
114 |
$4K |
| 87634 |
|
51 |
50 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
40 |
40 |
$3K |
| 99188 |
|
176 |
176 |
$3K |
| 87631 |
|
18 |
18 |
$2K |
| 96127 |
|
433 |
433 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
152 |
145 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
24 |
23 |
$2K |
| S9083 |
Global fee urgent care centers |
12 |
12 |
$2K |
| 92551 |
|
742 |
739 |
$837.19 |
| 87420 |
|
59 |
57 |
$717.42 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
26 |
25 |
$650.00 |
| 87070 |
|
62 |
59 |
$549.64 |
| 83655 |
|
24 |
24 |
$290.64 |
| 85018 |
|
51 |
51 |
$119.06 |
| 90686 |
|
591 |
588 |
$103.75 |
| 90651 |
|
41 |
41 |
$0.00 |
| 90680 |
|
166 |
166 |
$0.00 |
| 90698 |
|
203 |
203 |
$0.00 |
| 36416 |
|
54 |
54 |
$0.00 |
| 90744 |
|
46 |
46 |
$0.00 |
| 90716 |
|
12 |
12 |
$0.00 |
| 90670 |
|
459 |
459 |
$0.00 |
| 99080 |
|
154 |
68 |
$0.00 |
| 90734 |
|
51 |
51 |
$0.00 |
| 99173 |
|
63 |
63 |
$0.00 |
| 90633 |
|
38 |
38 |
$0.00 |
| 90707 |
|
34 |
34 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |